Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alamar Biosciences, Inc. - Class A common stock
(NQ:
ALMR
)
24.66
-1.25 (-4.82%)
Delayed Quote
Updated: 1:02 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alamar Biosciences, Inc. - Class A common stock
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
October 08, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
October 05, 2026
Strengthens leadership team with appointments of John Brottem as general counsel and Amelia Merrill as chief people officer
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
September 24, 2026
Blood biomarkers associated with amyloid clearance differ from those associated with cognitive decline in patients receiving lecanemab
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 01, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
August 10, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
August 10, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
July 28, 2026
Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive...
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
July 14, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
July 13, 2026
National-scale initiative will profile ~21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias (ADRD) participants using Alamar Biosciences' NULISAseq™ Neuro 220 panel. | Resulting...
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences Reports First Quarter 2026 Financial Results
May 08, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
May 05, 2026
From
Alamar Biosciences, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
